Chronic Heart Failure (CHF) Treatment in China — Get 3 Personalized Clinic Matches

Dr. Shen Yuqin, MD, PhD, is Professor and Chief Physician at Shanghai Tongji Hospital. Dr. Shen directs the Rehabilitation Medicine Center and the Cardiac Rehabilitation Department. A doctoral supervisor and National Advanced Worker, Dr. Shen is a pioneer in cardiac rehabilitation for heart failure.

Dr. Shen was the first in China to implement cardiopulmonary exercise testing (CPET)-guided rehabilitation for heart failure. Dr. Shen also introduced the use of the anaerobic threshold to prescribe exercise intensity. The team created a nationwide hospital–community–home closed-loop model. In 2020, they opened Shanghai’s only inpatient cardiac rehabilitation ward in a tertiary hospital.

Dr. Shen is the principal investigator of two NSFC General Projects. Honors include the CRMA Science and Technology Award, First Prize (2019), and the Shanghai Rehabilitation Medicine Science and Technology Progress Awards, First Prize (2018, 2024). Dr. Shen has published over 50 papers as first or corresponding author. Dr. Shen served as chief editor of one monograph and associate editor of two. The portfolio includes 22 patents (15 authorized, including three invention patents) and five software copyrights. Nine technology transfers have been completed.

Dr. Shen is a Fellow of the American Association of Cardiovascular and Pulmonary Rehabilitation (FAACVPR) and a CDQI certified expert. Dr. Shen serves as an associate editor and editorial board member. Dr. Shen led the drafting of eight consensuses, guidelines, and standards, and organized 20 national courses. The center has served more than 10,000 patients. The care model has been extended across Shanghai and introduced in Yunnan.

Dr. Xu Juntang, MD, is a Postdoctoral Fellow, Chief Physician, and Master’s Supervisor. He is the Director of Cardiovascular Medicine at Xiamen Humanity Hospital. His work focuses on preventing and treating cardiovascular and thrombotic diseases, including coronary artery disease, hypertension, heart failure, arrhythmias, and emergencies. He is skilled in cardiovascular biomarker testing.

He provides standardized care for thromboembolism related to valvular heart disease and non‑valvular atrial fibrillation, pulmonary embolism, deep vein thrombosis, and obstetric thrombophilia. He also conducts clinical and laboratory assessments of thrombosis and coagulation disorders. He is the Vice Chairman of the Laboratory and Clinical Branch of the Chinese Society of Cardiothoracic and Vascular Anesthesiology.

Dr. Yang Chuanhua is a specialist at Fosun Health and serves as Senior Vice President and Chief Medical Officer (CMO). Fosun Health describes his PhD background and nearly 40 years of work across clinical practice, teaching, and research, with a specific academic focus on hypertension, including difficult-to-treat cases. He is also recognized through memberships in TCM and cardiology-related organizations and provides traditional Chinese medicine–based diagnosis and health maintenance approaches.

Fu Guosheng is a professor associated with the Cardiology Department leadership at Sir Run Run Shaw Hospital. Under his leadership, SRRSH Cardiology—founded in 1994—supports medical care, teaching/training, and scientific research, and is described as a major cardiovascular intervention training base in China. The department’s interventional focus includes acute myocardial infarction, heart failure, refractory hypertension, valvular disease, and syncope.